S&P Pharmaceuticals SPDR (XPH)

$53.69 0.30 (0.56%)

19:59 EST XPH Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 3.03M

PE Ratio -

EPS -

Volume (Avg. Vol.) 23,500

Day's Range 53.23 - 53.99

52-Week Range 30.30 - 54.60

Dividend & Yield 0.24 (0.45%)

XPH Stock Predictions, Articles, and S&P Pharmaceuticals SPDR News

From InvestorPlace
From the Web

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

By Bret Kenwell, InvestorPlace Contributor Nov 17, 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

Apellis is Outperforming the Pharmaceutical Sector

By Ken Trester Apr 24, 2020

This week I want to take a bullish position in the underperforming pharmaceutical sector with Apellis Pharmaceuticals, Inc. (NASDAQ:APLS).

Use Johnson & Johnson for Quick Income

By Ken Trester Mar 17, 2020

Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.

Collect on the Pharmaceutical Boom With Eli Lilly

By Ken Trester Dec 17, 2019

Eli Lilly and Company (NYSE:LLY) provided optimistic guidance for 2020 today, and it looks like the stock will head higher at the open this morning.

3 Healthcare ETFs to Sell Amid Political Headwinds

By Todd Shriber, InvestorPlace Contributor Apr 23, 2019

While the rest of the market continues upward, the healthcare sector -- and healthcare ETFs -- continue to struggle.

5 Best-Performing Sector ETFs of July

By Zacks Investment Research Aug 2, 2018

We have highlighted sector ETFs that witnessed handsome gains last month and could be better plays in the months ahead should the trends prevail. Compare Broker....

7 Best Healthcare ETFs for the Rest of 2018

By Todd Shriber, InvestorPlace Contributor Mar 8, 2018

Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.